SLC5A2 and renal fibrosis: (a) Senolytics—improve adiponectin profile, attenuate renal fibrosis, and augment renal cortical oxygenation(b) RAS inhibitors—lower visceral fat and WAT leptin secretion(c) SGLT2 inhibitors—prevent glomerular hyperfiltration and hinder renal damage progression